Table 2.
Sex and age-specific prevalence of the MS according to WHO, modified ATP III and IDF definition among selected Chinese adults in Pudong New Area of Shanghai, China
| No. of Subjects | WHO criteria | ATP III criteria | IDF criteria | ||||
|---|---|---|---|---|---|---|---|
| No. of MS | % | No. of MS | % | No. of MS | % | ||
| Male | |||||||
| 2477 | 498 | 20.2(15.3) | 696 | 28.4(22.7) | 391 | 15.9(13.8) | |
| 20- | 141 | 3 | 2.1 | 10 | 7.1 | 9 | 6.4 |
| 25- | 124 | 6 | 4.9 | 17 | 14.1 | 14 | 11.6 |
| 30- | 134 | 8 | 6.1 | 16 | 12.2 | 12 | 9.2 |
| 35- | 142 | 22 | 15.8 | 26 | 18.7 | 17 | 12.2 |
| 40- | 204 | 35 | 17.2 | 54 | 26.7 | 34 | 16.8 |
| 45- | 314 | 55 | 17.5 | 74 | 23.7 | 38 | 12.2 |
| 50- | 309 | 76 | 19.6 | 114 | 29.5 | 61 | 15.8 |
| 55- | 348 | 85 | 24.6 | 117 | 33.9 | 61 | 17.7 |
| 60- | 258 | 80 | 31.3 | 103 | 40.2 | 51 | 19.9 |
| 65- | 162 | 51 | 31.7 | 68 | 42.5 | 38 | 23.8 |
| 70- | 173 | 44 | 25.4 | 62 | 35.8 | 34 | 19.7 |
| 75- | 88 | 33 | 37.5 | 35 | 40.2 | 22 | 25.3 |
| Female | |||||||
| 3107 | 575 | 18.7(12.3) | 1078 | 35.1(25.0) | 821 | 26.7(19.2) | |
| 20- | 159 | 0 | 0 | 3 | 1.9 | 3 | 1.9 |
| 25- | 176 | 3 | 1.8 | 15 | 8.8 | 14 | 8.2 |
| 30- | 156 | 3 | 1.9 | 13 | 8.4 | 10 | 6.5 |
| 35- | 186 | 8 | 4.4 | 33 | 17.9 | 28 | 15.2 |
| 40- | 274 | 20 | 7.4 | 48 | 17.8 | 34 | 12.6 |
| 45- | 395 | 59 | 15.0 | 113 | 28.8 | 83 | 21.1 |
| 50- | 551 | 98 | 17.9 | 205 | 37.6 | 149 | 27.3 |
| 55- | 468 | 123 | 26.5 | 210 | 45.2 | 172 | 37.0 |
| 60- | 265 | 80 | 30.2 | 147 | 55.5 | 110 | 41.5 |
| 65- | 189 | 59 | 31.9 | 96 | 52.5 | 71 | 38.8 |
| 70- | 188 | 75 | 39.9 | 130 | 69.5 | 99 | 52.9 |
| 75- | 100 | 47 | 47.5 | 65 | 65.7 | 48 | 48.5 |
In parentheses was the age-standardized prevalence of the MS according to age distribution of the world population.